Toyobo Co Ltd (TYOBF)
OTHER OTC:TYOBF
TYOBF Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Diversified Product PortfolioToyobo's broad portfolio—synthetic fibers, films/plastics, functional/advanced materials and bio-related products—provides durable revenue diversification across apparel, packaging and industrial end-markets. This multi-end-market exposure reduces reliance on any single cycle and supports steadier demand over months.
Sustained Revenue Growth TrendA multi-year top-line expansion culminating in a strong 2026 rebound signals improving commercial traction and scale. Sustained revenue growth supports capacity utilization and the ability to invest in higher-margin functional materials, strengthening long-term margin and cash-generation potential.
Improving Cash GenerationThe recovery in operating cash flow and return to positive free cash flow in 2026 indicate the company can generate internal funds to support operations and selective investment. Improved cash conversion reduces near-term refinancing needs and supports funding of R&D or capex over months ahead.
Bears Say
Elevated LeverageMaterial net debt and a debt-to-equity ratio around 1.0–1.37 constrain financial flexibility. With sizable interest and principal obligations, leverage heightens refinancing and earnings-risk in cyclical downturns and limits capacity for strategic M&A or accelerated capex without increasing funding risk.
Volatile And Thin ProfitabilityEarnings have swung from losses to modest profits and then a rebound, indicating sensitivity to input costs and cyclical demand. Thin and inconsistent margins reduce predictability of sustained earnings power, complicating long-term planning and capital allocation over the next several quarters.
Uneven Cash Conversion HistoryMulti-year negative free cash flow and prior operating cash volatility point to heavy capex or working-capital swings. This inconsistency increases reliance on external financing during weaker periods, raising refinancing and liquidity risk and limiting durable self-funded growth without careful working-capital management.
Toyobo Co News
TYOBF FAQ
What was Toyobo Co Ltd’s price range in the past 12 months?
Currently, no data Available
What is Toyobo Co Ltd’s market cap?
Toyobo Co Ltd’s market cap is $1.03B.
When is Toyobo Co Ltd’s upcoming earnings report date?
Toyobo Co Ltd’s upcoming earnings report date is Aug 10, 2026 which is in 62 days.
How were Toyobo Co Ltd’s earnings last quarter?
Toyobo Co Ltd released its earnings results on May 12, 2026. The company reported $0.239 earnings per share for the quarter, beating the consensus estimate of N/A by $0.239.
Is Toyobo Co Ltd overvalued?
According to Wall Street analysts Toyobo Co Ltd’s price is currently Undervalued.
Does Toyobo Co Ltd pay dividends?
Toyobo Co Ltd does not currently pay dividends.
What is Toyobo Co Ltd’s EPS estimate?
Toyobo Co Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Toyobo Co Ltd have?
Currently, no data Available
What happened to Toyobo Co Ltd’s price movement after its last earnings report?
Toyobo Co Ltd reported an EPS of $0.239 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Toyobo Co Ltd?
Currently, no hedge funds are holding shares in TYOBF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Toyobo Co Ltd
Established in 1882 and headquartered in Osaka, Japan, Toyobo Co., Ltd. is a global enterprise delivering a diverse range of products. The company specializes in the manufacturing of films and advanced polymers, industrial components, healthcare solutions, and various textile goods. Its films and functional polymers division produces industrial PET films for applications such as liquid crystal displays and optics, in addition to synthetic papers. It also supplies a variety of packaging films, including PET, polyolefin, and nylon options for food products, along with heat-shrink PET films. The company's portfolio of functional polymers features engineering plastics, industrial adhesives, specialized coatings, photosensitive printing plates, acrylate polymers, and electronic materials. This segment further encompasses rubber and coat processing, as well as pharmaceutical intermediates. Within its industrial materials segment, Toyobo develops functional fibers for airbag construction, polyethylene fibers, and PBO fibers. It also creates functional filters for automotive and indoor environments, materials for anti-pollution solvent adsorption, and fiber components utilized in vehicle parts. In the healthcare sector, the company provides a comprehensive selection of bio-products, which includes enzymes for diagnostic purposes, diagnostic systems, and research reagents. Its contributions also extend to artificial kidney hollow fibers, anti-clotting substances, and seawater desalination modules. For textiles, Toyobo supplies functional fabrics suitable for sports clothing, undergarments, and uniforms, alongside synthetic filaments. The company markets apparel under its Munsingwear brand, acrylic fibers under Exlan, and acrylate fibers under the eks brand, while also engaging in general textile product commerce. Beyond these offerings, Toyobo serves as a contract manufacturer for injectable pharmaceuticals.